CIK 0001464165 · Pharmaceutical Preparations (SIC 2834) · OTC · incorporated in A1 · fiscal year ends 01/31
| FY2019 | FY2015 | |
|---|---|---|
| Net income (CAD) | -9146371 | -1257047 |
| Diluted EPS (CAD/shares) | -0.11 |
| Filed | Form | Description | Period |
|---|---|---|---|
| 2026-09-30 | 6-K | FORM 6-K | 2026-09-29 |
| 2026-09-22 | SCHEDULE 13G | SCHEDULE 13G | |
| 2026-09-15 | 6-K | FORM 6-K | 2026-09-14 |
| 2026-09-11 | 6-K | FORM 6-K | 2026-09-11 |
| 2026-08-24 | 6-K | FORM 6-K | 2026-08-24 |
| 2026-08-05 | 6-K | FORM 6-K | 2026-08-03 |
| 2026-06-26 | 6-K | FORM 6-K | 2026-04-30 |
| 2026-06-25 | 6-K | FORM 6-K | 2026-06-25 |
| 2026-06-01 | 20-F | FORM 20-F | 2026-01-31 |
| 2026-04-13 | 6-K | FORM 6-K | 2026-04-13 |
| 2025-09-29 | 6-K | FORM 6-K | 2025-09-26 |
| 2025-07-28 | 6-K | FORM 6-K | 2025-07-28 |
| 2025-06-27 | 6-K | FORM 6-K | 2025-04-30 |
| 2025-06-23 | 6-K | FORM 6-K | 2025-06-23 |
| 2025-06-02 | 20-F | FORM 20-F | 2025-01-31 |
| 2025-05-30 | 6-K | FORM 6-K | 2025-05-29 |
| 2025-05-07 | 6-K | FORM 6-K | 2025-05-06 |
| 2025-04-07 | 6-K | FORM 6-K | 2025-04-07 |
| 2024-12-31 | 6-K | FORM 6-K | 2024-10-31 |
| 2024-12-09 | 6-K | FORM 6-K | 2024-12-09 |
| 2024-10-15 | 6-K | FORM 6-K | 2024-10-15 |
| 2024-09-26 | 6-K | FORM 6-K | 2024-07-31 |
| 2024-08-29 | 6-K | FORM 6-K | 2024-08-29 |
| 2024-08-08 | 6-K | FORM 6-K | 2024-08-07 |
| 2024-07-15 | 6-K | FORM 6-K | 2024-07-15 |
Forms on file (last 1,000): 6-K 111, 10-Q 28, 8-K 26, 10-K 10, 20-F 7, NT 10-Q 7, NT 10-K 7, UPLOAD 7. Source: SEC EDGAR, as filed; this page is public data and not investment advice.
GET https://store.agentexchange.work/gw/filings/company?ticker=BETRF (0.002 USD), /gw/filings/filings?ticker=BETRF&form=8-K, /gw/filings/facts?ticker=BETRF&concept=Revenues, full-text /gw/filings/search?q=.... Pay per call in USDC (x402) or with a 19 USD card key for 1,000 calls. Catalogue · llms.txtUpdated from EDGAR within 30 minutes of a filing. Agent Exchange